BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23895350)

  • 1. Hormone therapy for female sexual function during perimenopause and postmenopause: a Cochrane review.
    Martins WP; Lara LA; Ferriani RA; Rosa-E-Silva AC; Figueiredo JB; Nastri CO
    Climacteric; 2014 Apr; 17(2):133-5. PubMed ID: 23895350
    [No Abstract]   [Full Text] [Related]  

  • 2. Sexual dysfunction in the peri- and postmenopause. Status of incidence, pharmacological treatment and possible risks. A secondary publication.
    Gregersen N; Jensen PT; Giraldi AE
    Dan Med Bull; 2006 Aug; 53(3):349-53. PubMed ID: 17092454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menopause, estrogens, progestins, or their combination on body weight and anthropometric measures.
    Cagnacci A; Zanin R; Cannoletta M; Generali M; Caretto S; Volpe A
    Fertil Steril; 2007 Dec; 88(6):1603-8. PubMed ID: 17481628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Italian position statement on hormone replacement therapy following the National Conference on Menopause and Hormone Replacement Therapy, Villa Tuscolana, Frascati (Rome), May 8-9, 2007.
    Genazzani A; Gambacciani M; Simoncini T; Anniverno R; Becorpi AM; Biglia N; Brandi ML; Guaschino S; Lello S; Massobrio M; Melis GB; Mencacci C; Modena MG; Nappi C; Nappi RE; Pecorelli S; Petraglia F; Rosano GM; Serra GB; Sismondi P; Taddei S; Tonelli F
    Gynecol Endocrinol; 2007; 23(8):436-44. PubMed ID: 17934930
    [No Abstract]   [Full Text] [Related]  

  • 5. [Sexual dysfunction in the menopause. Incidence, pharmacological treatment and side effects].
    Gregersen N; Hilmand CB; Jensen PT; Giraldi AG
    Ugeskr Laeger; 2006 Feb; 168(6):559-63. PubMed ID: 16476214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.
    Ziaei S; Moghasemi M; Faghihzadeh S
    Climacteric; 2010 Apr; 13(2):147-56. PubMed ID: 19731119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progestins and recurrence in breast cancer survivors.
    Chlebowski RT; Anderson GL
    J Natl Cancer Inst; 2005 Apr; 97(7):471-2. PubMed ID: 15812065
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of vulvovaginal atrophy-related sexual dysfunction in postmenopausal women: an up-to-date review.
    Tan O; Bradshaw K; Carr BR
    Menopause; 2012 Jan; 19(1):109-17. PubMed ID: 22011753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Female sexual dysfunction and use of hormone therapy in postmenopausal women.
    Kovalevsky G
    Semin Reprod Med; 2005 May; 23(2):180-7. PubMed ID: 15852204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new verdict for hormone therapy: safe for younger women.
    Knotts JL; Childers WA
    JAAPA; 2009 Dec; 22(12):46-51. PubMed ID: 24887468
    [No Abstract]   [Full Text] [Related]  

  • 12. Spanish Menopause Society position statement: use of tibolone in postmenopausal women.
    Mendoza N; Abad P; Baró F; Cancelo MJ; Llaneza P; Manubens M; Quereda F; Sánchez-Borrego R
    Menopause; 2013 Jul; 20(7):754-60. PubMed ID: 23793166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Did the decrease in use of menopausal hormone therapy induce a decrease in the incidence of breast cancer in France (and elsewhere)?].
    Ringa V; Fournier A
    Rev Epidemiol Sante Publique; 2008 Oct; 56(5):297-301. PubMed ID: 18947946
    [No Abstract]   [Full Text] [Related]  

  • 14. New products and regimens (since 2003).
    Panay N
    Climacteric; 2007 Oct; 10 Suppl 2():109-14. PubMed ID: 17882685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [When libido stops].
    Schwenkhagen A
    MMW Fortschr Med; 2006 Jun; 148(25):54-5. PubMed ID: 16859166
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of hormone therapy on quality of life after menopause.
    Utian WH; Woods NF
    Menopause; 2013 Oct; 20(10):1098-105. PubMed ID: 23799357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future long-term trials of postmenopausal hormone replacement therapy - what is possible and what is the optimal protocol and regimen?
    Purbrick B; Stranks K; Sum C; MacLennan AH
    Climacteric; 2012 Jun; 15(3):288-93. PubMed ID: 22612617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are the benefits of low-dose estrogens really proven?
    Studd J
    Climacteric; 2008 Oct; 11(5):438. PubMed ID: 18781491
    [No Abstract]   [Full Text] [Related]  

  • 19. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia: a Cochrane review summary.
    Roberts H; Hickey M; Lethaby A
    Maturitas; 2014 Jan; 77(1):4-6. PubMed ID: 24182544
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of different preparations of hormone therapy on sexual dysfunction in naturally postmenopausal women.
    Osmanağaoğlu MA; Atasaral T; Baltaci D; Bozkaya H
    Climacteric; 2006 Dec; 9(6):464-72. PubMed ID: 17085380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.